NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-348 MEMO

1. 48869 HIV-LS-348; EMBASE-HIV-5/15/2006

Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors

Randolph, John T, Huang, Peggy P, Flosi, William J, DeGoey, David, Klein, Larry L, Yeung, Clinton M, Flentge, Charles, Sun, Mingua, Zhao, Chen, and Dekhtyar, Tatyana

Bioorganic & Medicinal Chemistry 2006. 14(12): 4035-4046


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4JCBN69-5/2/359cbaf21b0bba60c34e8493cd2f50ea


2. 48870 HIV-LS-348; PUBMED-HIV-5/15/2006

Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease

Davis, DA, Brown, CA, Singer, KE, Wang, V, Kaufman, J, Stahl, SJ, Wingfield, P, Maeda, K, Harada, S, Yoshimura, K, Kosalaraksa, P, Mitsuya, H, and Yarchoan, R

Antiviral Res 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16687179&dopt=abstract


3. 48871 HIV-LS-348; EMBASE-HIV-5/15/2006

Mechanism of Drug Resistance Revealed by the Crystal Structure of the Unliganded HIV-1 Protease with F53L Mutation

Liu, Fengling, Kovalevsky, Andrey Y, Louis, John M, Boross, Peter I, Wang, Yuan-Fang, Harrison, Robert W, and Weber, Irene T

Journal of Molecular Biology 2006. 358(5): 1191-1199


HYPERLINK:

http://www.sciencedirect.com/science/article/B6WK7-4JHMHCT-4/2/e5dd2681a5918c5811fc1790d45500b4


4. 48872 HIV-LS-348; PUBMED-HIV-5/15/2006

Synthesis, anti-HIV and antitubercular activities of isatin derivatives

Sriram, D, Yogeeswari, P, and Meena, K

Pharmazie 2006. 61(4): 274-7


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16649536&dopt=abstract


5. 48873 HIV-LS-348; EMBASE-HIV-5/15/2006

Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion

Gomara, Maria J, Lorizate, Maier, Huarte, Nerea, Mingarro, Ismael, Perez-Paya, Enrique, and Nieva, Jose L

FEBS Letters 2006. 580(11): 2561-2566


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T36-4JSF4WN-9/2/c471ea4fb4bfd626149bc29ba5492b08



6. 48874 HIV-LS-348; PUBMED-HIV-5/15/2006

theta -Defensins prevent HIV-1 env-mediated fusion by binding gp41 and blocking 6-helix bundle formation

Gallo, SA, Wang, W, Rawat, SS, Jung, G, Waring, AJ, Cole, AM, Lu, H, Yan, X, Daly, NL, Craik, DJ, Jiang, S, Lehrer, RI, and Blumenthal, R

J Biol Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16648135&dopt=abstract


7. 48875 HIV-LS-348; EMBASE-HIV-5/15/2006

HIV co-receptor inhibitors as novel class of anti-HIV drugs

Schols, Dominique

Antiviral Research 2006. In Press, Uncorrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T2H-4JWMSCF-3/2/97a23695f4e3249b71f681c276f5ee14


8. 48876 HIV-LS-348; PUBMED-HIV-5/15/2006

Cyclophilin A renders human immunodeficiency virus type 1 sensitive to old world monkey but not human TRIM5{alpha} antiviral activity

Keckesova, Z, Ylinen, LM, and Towers, GJ

J Virol 2006. 80(10): 4683-90


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16641261&dopt=abstract


9. 48877 HIV-LS-348; PUBMED-HIV-5/15/2006

Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity

Imamura, S, Ichikawa, T, Nishikawa, Y, Kanzaki, N, Takashima, K, Niwa, S, Iizawa, Y, Baba, M, and Sugihara, Y

J Med Chem 2006. 49(9): 2784-93


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16640339&dopt=abstract


10. 48878 HIV-LS-348; EMBASE-HIV-5/15/2006

Clinical pharmacodynamics of HIV-1 protease inhibitors: use of inhibitory quotients to optimise pharmacotherapy

Morse, Gene D, Catanzaro, Linda M, and Acosta, Edward P

The Lancet Infectious Diseases 2006. 6(4): 215-225


HYPERLINK:

http://www.sciencedirect.com/science/article/B6W8X-4JHV0JG-P/2/980f0a967c7019304ef409595b76bb05



11. 48879 HIV-LS-348; PUBMED-HIV-5/15/2006

Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity

Ferguson, MR, Rojo, DR, Somasunderam, A, Thiviyanathan, V, Ridley, BD, Yang, X, and Gorenstein, DG

Biochem Biophys Res Commun 2006. 344(3): 792-7


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16631118&dopt=abstract


12. 48880 HIV-LS-348; PUBMED-HIV-5/15/2006

Synthesis and antiviral evaluation of novel open-chain analogues of neplanocin A

Hong, JH, Kim, SY, Oh, CH, Yoo, KH, and Cho, JH

Nucleosides Nucleotides Nucleic Acids 2006. 25(3): 341-50


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16629127&dopt=abstract


13. 48881 HIV-LS-348; PUBMED-HIV-5/15/2006

A new structural theme in C(2)-symmetric HIV-1 protease inhibitors: ortho-Substituted P1/P1' side chains

Wannberg, J, Sabnis, YA, Vrang, L, Samuelsson, B, Karlen, A, Hallberg, A, and Larhed, M

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16621572&dopt=abstract


14. 48882 HIV-LS-348; PUBMED-HIV-5/15/2006

Antiviral drug resistance

Richman, DD

Antiviral Res 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16621040&dopt=abstract


15. 48883 HIV-LS-348; PUBMED-HIV-5/15/2006

HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription

Caldwell, RL, Lane, KB, and Shepherd, VL

Arch Biochem Biophys 2006. 449(1-2): 27-33


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16615932&dopt=abstract


16. 48884 HIV-LS-348; WOS-HIV-5/7/2006

Evolutionary dynamics of HIV-1 and the control of AIDS

Mullins, JI and Jensen, MA

QUASISPECIES: CONCEPT AND IMPLICATIONS FOR VIROLOGY 2006. 299: 171-192, 22


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000236797900006


17. 48885 HIV-LS-348; WOS-HIV-5/7/2006

Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces tat-independent HIV-1 expression but blunts cell activation

Klichko, V, Archin, N, Kaur, R, Lehrman, G, and Margolis, D

JOURNAL OF VIROLOGY 2006. 80(9): 4570-4579, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000236980000038


18. 48886 HIV-LS-348; WOS-HIV-5/7/2006

Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors

Geitmann, M, Unge, T, and Danielson, UH

JOURNAL OF MEDICINAL CHEMISTRY 2006. 49(8): 2367-2374, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000236979100002


19. 48887 HIV-LS-348; WOS-HIV-5/7/2006

Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance

Geitmann, M, Unge, T, and Danielson, UH

JOURNAL OF MEDICINAL CHEMISTRY 2006. 49(8): 2375-2387, 13


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000236979100003


20. 48888 HIV-LS-348; WOS-HIV-5/7/2006

Further screening of Venda medicinal plants for activity against HIV type 1 reverse transcriptase and integrase

Bessong, PO, Rojas, LB, Obi, LC, Tshisikawe, PM, and Igunbor, EO

AFRICAN JOURNAL OF BIOTECHNOLOGY 2006. 5(6): 526-528, 3


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237014700008


21. 48889 HIV-LS-348; WOS-HIV-5/14/2006

Fast and selective synthesis of novel cyclic sulfamide HIV-1 protease inhibitors under controlled microwave heating

Gold, H, Ax, A, Vrang, L, Samuelsson, B, Karlen, A, Hallberga, A, and Larhed, M

TETRAHEDRON 2006. 62(19): 4671-4675, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237126500006


22. 48890 HIV-LS-348; WOS-HIV-5/14/2006

Divergent synthesis and biological evaluation of carbocyclic alpha-, iso- and 3 '-epi-nucleosides and their lipophilic nucleotide prodrugs

Ludek, OR, Kramer, T, Balzarini, J, and Meier, C

SYNTHESIS-STUTTGART 2006.(8): 1313-1324, 12


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237076800014


23. 48891 HIV-LS-348; WOS-HIV-5/14/2006

Advances in human immunodeficiency virus therapeutics

Clay, PG, Dong, BJ, Sorensen, SJ, Tseng, A, Rornanelli, F, and Antoniou, T

ANNALS OF PHARMACOTHERAPY 2006. 40(4): 704-709, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237005900017


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021